Why is Shukra Pharma. falling/rising?

As of 01-Sep, Shukra Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 26.74, reflecting a rise of Rs 0.52 or 1.98%. The stock has shown impressive performance, gaining 48.97% over the last 10 days and is currently trading close to its 52-week high, just 1.53% away from Rs 27.15. Additionally, it has outperformed its sector by 2.01% today. The stock's strong upward trajectory is supported by its consistent returns, having generated a remarkable 309.62% return over the past year and outperforming the BSE500 in each of the last three annual periods. The company's healthy long-term growth is underscored by an annual operating profit growth rate of 62.04%, and its low Debt to EBITDA ratio of 1.28 times indicates a strong ability to service debt.
In the broader market context, Shukra Pharmaceuticals has significantly outperformed the benchmark Sensex, which has declined by 1.56% over the past week while Shukra's stock has surged by 11.37%. This stark contrast highlights the stock's strength relative to the market, particularly as it continues to trade above all key moving averages. The rising investor participation, evidenced by a 14.77% increase in delivery volume, further emphasizes the stock's liquidity and attractiveness to investors. Overall, the combination of strong financial performance, positive market sentiment, and robust trading activity contributes to the stock's rising price.